Excelra, a life science data and digital solutions provider, acquired BISC Global, a bioinformatics and data analytics consulting company with offices across Europe and the USA.
The amount of the deal was not disclosed.
The acquisition extends Excelra’s artificial intelligence, machine learning, and data science capabilities, and enhances its platform and service portfolio.
BISC Global is a consulting-led platform and service provider specializing in bioinformatics, biostatistics, artificial intelligence, and machine learning. It provides data analysis, pipeline development, cloud computing, and data visualization services. It also offers platforms such as the Online Pipeline Platform (OP2), which supports streamlined analysis of bulk RNA-seq, single-cell RNA-seq, somatic variant calling, and germline variant calling data; and ImmunoRaptor, an analysis platform that makes it easy for researchers to manage and analyze immune repertoire sequencing data. It has a global workforce of expert consultants, operating from offices in Ghent, Belgium; Basel, Switzerland; Amsterdam, The Netherlands; Boston, MA; and San Francisco, CA.
Led by CEO Anandbir Singh Brar, Excelra is a partner to the world’s top pharmaceutical and biotechnology companies, providing data, insight, and R&D technology services. Its interdisciplinary teams of biocurators, bioinformaticians, data scientists, and engineers deliver harmonized data, optimized analysis pipelines, and advanced applications to accelerate drug discovery and development.
The company has offices in Boston, Utrecht, London, and Hyderabad.
FinSMEs
19/04/2023